Boiron To Pay Up To $12M To End False Advertising Suits

Law360, New York (March 7, 2012, 1:47 PM EST) -- French homeopathic medicine giant Boiron Inc. agreed on Tuesday to spend up to $12 million to settle several putative consumer class actions claiming it falsely advertised the benefits of its homeopathic remedies.

Boiron will put up $5 million to cover consumers seeking refunds on Boiron products they purchased, according to the proposed settlement filed in California federal court. Refunds are capped at $100 per household, the settlement said.

Boiron also agreed to make changes to the labeling of its products, including adding a disclaimer stating that their uses have not been evaluated by the U.S. Food and Drug Administration and an...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!